HSIGI: Intraoperative Hyperspectral Imaging in Gastrointestinal Anastomoses

Sponsor
University of Leipzig (Other)
Overall Status
Unknown status
CT.gov ID
NCT03667950
Collaborator
(none)
200
1
1
29
6.9

Study Details

Study Description

Brief Summary

In this study, gastrointestinal anastomoses are examined with a hyperspectral camera.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Hyperspectral Imaging
N/A

Detailed Description

The anastomoses were examined under standardized conditions directly after creation. The measurements were performed like described before, using the TIVITA Tissue system (Diaspective Vision GmbH, Am Salzhaff, Germany). This HSI-camera provides hyperspectral images with a high spectral resolution (5 nm) in the visible and near infrared range (500-1000 nm). The distance between camera and object was 30 cm for all measurements. The Number of Effective Pixels at this distance is 640 × 480 (x-, y-axis. The resulting field of view (FOV) has the dimensions 6.4 × 4.8 cm2 and a spatial resolution of 0.1 mm/pixel. The FOV is illuminated by 8 halogen spots (20 W each). The ceiling lights and other light sources were switched off, to avoid artifacts during the measurement (approximately 10 seconds). A RGB image and 4 false color images that represent physiologic parameters are intraoperatively provided by an analysis software. This work is focused on tissue oxygenation (StO2), which represents the relative blood oxygenation in the microcirculation of superficial tissue layers (approximately 1 mm) and the near-infrared (NIR) Perfusion Index, representing tissue layers in 4-6 mm penetration depth.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Vascular Border Zone Definition Using Intraoperative Hyperspectral Imaging for Resections and Reconstructions in Diseases of the Esophagus, Stomach, Pancreas, Small Intestine, Large Intestine and Rectum to Optimize Anastomotic Healing
Actual Study Start Date :
Aug 1, 2018
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Jan 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: hyperspectral imaging

diagnostic hyperspectral Imaging of the gastrointestinal anastomosis and calculating the anastomotic Perfusion measures

Procedure: Hyperspectral Imaging
Photos were taken with the hyperspectral camera of the gastrointestinal anastomosis.

Outcome Measures

Primary Outcome Measures

  1. Anastomotic Perfusion: (Oxygenation (StO2) [direct during the Operation (ca. 15-20 Minutes)]

    Oxygenation (StO2) in %: Relative O2 saturation of the blood immicrocircular system in superficial tissue layers (penetration depth: approx. 1 mm)

  2. Anastomotic Perfusion: Tissue-Hemoglobin index [direct during the Operation (ca. 15-20 Minutes)]

    Tissue Hemoglobin index in %: Existing hemoglobin distribution in the microcircular system of the tissue area under consideration (index value)

  3. Anastomotic Perfusion: Near Infrared Perfusion Index [direct during the Operation (ca. 15-20 Minutes)]

    Near Infrared Perfusion Index in %: Relative O2 saturation of the blood immicrocircular system in deeper tissue layers (penetration depth: 4-6mm; index value)

  4. Anastomotic Perfusion: Tissue-Water-Index [direct during the Operation (ca. 15-20 Minutes)]

    Tissue-Water-Index in %: Existing water distribution in the tissue area under consideration (index value)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • all gastrointestinal anastomoses
Exclusion Criteria:
  • inability to consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universitätsklinikum Leipzig - AöR Leipzig Sachsen Germany 04103

Sponsors and Collaborators

  • University of Leipzig

Investigators

  • Principal Investigator: Boris Jansen-Winkeln, Dr., University of Leipzig

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr. Boris Jansen-Winkeln, Dr., University of Leipzig
ClinicalTrials.gov Identifier:
NCT03667950
Other Study ID Numbers:
  • HSIGI
First Posted:
Sep 12, 2018
Last Update Posted:
Oct 31, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Boris Jansen-Winkeln, Dr., University of Leipzig

Study Results

No Results Posted as of Oct 31, 2019